GRDN
Guardian Pharmacy Services, Inc.
Consumer Discretionary • CIK: 0001802255
Loading...
Market Cap
$1.35B
P/E (TTM)
38.0x
Rev Growth (TTM)
+18.7%
Net Margin (TTM)
2.9%
FCF Yield (TTM)
6.5%
FCF Margin (TTM)
6.3%
Cash Flow Health
Free Cash Flow7/8 positive
TTM$88M
Q3 '25
$24M+21%
Q2 '25
$20M+14%
FCF Margin
TTM6.3%
Q3 '256.4%+11%
Sector: 3.2%Above Avg
OCF Margin6.3%
OCF/NI2.19x
CapEx Coverage–
FCF Yield6.5%
FCF Growth (2Y)–
Cash Conversion Cycle
5 days
DSO: 25+DIO: 14−DPO: 35
Capital Allocation & Returns
Total Shareholder YieldFY
FY0.0%
Div Yield0.0%
+Buyback (FY)4.4%
Insufficient data
Dividend & Payout Metrics
Dividend Yield (TTM)0.0%
Free Cash Flow (TTM)$88.0M
Stock Repurchases (FY)$55.2M
Capital Return / FCF0.0%
Est. Dividends Paid (TTM)$0
Shows how management rewards shareholders
Operational Efficiency & Returns
Return on Invested CapitalTTM
20.8%
P25MedianP75
75th pctl (med: 0.1%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
2.9%
8Q: 2.8%
Asset Turnover
4.03x
8Q: 4.03x
Leverage (1+D/E)
–
Asset & CapEx Efficiency
Fixed Asset Turn
26.74x
8Q:–
Invested Cap Turn
7.28x
8Q:–
Asset-based ROIC formula
QUARTERLY TRENDS
Last 8 quarters + TTM
| Metric | TTM | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | $1.4B | $377.4M↑9.6% | $344.3M↑4.6% | $329.3M↓2.7% | $338.6M↑7.7% | $314.4M↑4.8% | $300.0M↑8.9% | $275.4M↓2.0% | $281.1M |
Operating Income | $58.7M | $16.4M↑30.0% | $12.6M↓3.3% | $13.0M↓22.4% | $16.8M↑116.0% | $-104.6M↓715.2% | $17.0M↑114.4% | $7.9M↓48.9% | $15.5M |
Net Income | $40.2M | $9.8M↑8.7% | $9.0M↓4.4% | $9.4M↓20.9% | $11.9M↑109.8% | $-122.0M | $0↓100.0% | $7.1M↓51.3% | $14.6M |
Operating Cash Flow | $88.0M | $28.2M↑41.3% | $19.9M↑13.6% | $17.6M↓21.4% | $22.3M↑1132.2% | $-2.2M↓107.4% | $29.1M↑236.6% | $8.7M↓40.5% | $14.6M |
Free Cash Flow | $88.0M | $24.2M↑21.2% | $19.9M↑13.6% | $17.6M↓12.6% | $20.1M↑558.5% | $-4.4M↓115.0% | $29.1M↑236.6% | $8.7M↓40.5% | $14.6M |
Total Equity | N/A |
Valuation Analysis
Fair Value
Price-to-EarningsTTM
38.0x
Valuation Lenses
Earnings
38.0x
vs – sector
Cash Flow
-0.2x
EV/FCF vs –
Growth-Adj
2.0xPEG
Expensive for growth
Quality-Adj
1.8P/E per %ROIC
ROIC: 20.8%
Shareholder Returns
Dividend
–
Buyback
–
Total Yield
–
Market Cap$1.35B
EV–
Multi-angle valuation analysis with sector context
Business Quality & Moat
Overall Quality Score
100/100
Exceptional
Composite score: Returns (40%) + Consistency (30%) + Earnings Quality (30%)
Returns on Capital
Return on Equity (ROE)
–
8Q:–
Return on Invested Capital (ROIC)Top 25%
20.8%
8Q:–
vs Sector:0.1%
DuPont Analysis (ROIC = NOPAT Margin × Asset Turnover)
NOPAT Margin: 2.9%
Asset Turnover: 4.03x
Earnings Quality
Cash Conversion
2.19x
OCF / Net Income ✓
FCF Consistency
–
Positive quarters
Competitive Moat Indicators
Pricing Power
Gross Margin19.7%
Capital Efficiency
Invested Capital Turnover7.28x
Working Capital
Cash Conversion Cycle5 days
Growth Quality & Momentum
Moderate Growth
Growth Quality Score
69/100
Growth 40%
Margins 30%
FCF 20%
Consistency 10%
Growth Rates
Revenue Growth YoY
18.7%
OpInc Growth YoY
115.6%
EPS Growth YoY
N/A
FCF 3Y CAGR
N/A
Margin Quality & Sustainability
Low Quality
Profitability Cascade
Gross
19.7%
Operating
4.2%
Below Avg in sector
Net
2.9%
Margins Unknown
Earnings Quality Signals
SBC / Revenue
—
FCF vs Net Gap
+3.4 pts
FCF: 6.3% | Net: 2.9%
Quality = stability + cash conversion + low dilution
Balance Sheet & Solvency
Fortress
Net Debt / EBITDA
Net Cash
(0.0x)Net Cash: $36.49M
Interest Coverage
–
+Net cash position: $36.49M
Leverage Metrics
Debt-to-Equity
–x
Balance sheet risk & solvency analysis